ESTRO 2023 - Abstract Book

S1954

Digital Posters

ESTRO 2023

In contrast to the AAPM TG43, commercially available model-based dose calculation algorithms for brachytherapy account for the effect of heterogeneities, the catheter material and shape as well as the limited scatter conditions in bounded patient anatomy for dose calculation. Previous comparison studies have focused on the dosimetric differences within high dose-rate (HDR) interstitial treatment of the breast, but in this work, we also focus on head-and-neck and lung. A retrospective comparison was made between TG43 and AcurosTM BV algorithms, found in the BrachyVisionTM treatment planning system (Varian Medical Systems Inc., CA, USA). Differences of plan quality indices were computed for multi catheter HDR brachytherapy implants in breast, head-and-neck, and lung, where the proximity of the treated clinical target volumes to bounded and/or heterogeneous anatomy raise a dosimetric accuracy concern. Materials and Methods A total of 64 patients treated with interstitial HDR brachytherapy at our centre, were retrospectively assessed (24 breast, 23 head-and-neck, 17 lung). Treatment plans were created for each case using the TG43 algorithm and then re-calculated using the AcurosBV algorithm with the option of calculating dose to medium in medium. Dose volume histogram (DVH) statistics have been generated for each plan, concentrating on the coverage of the planning target volume (PTV) and clinically meaningful metrics for relevant organs at risk (OARs) such as skin and healthy lung. Maximum and mean deviations of these metrics between the two algorithms, for each anatomical site were assessed. Results Using TG43, increased dose coverage of the PTV was observed when compared to the AcurosBV dose calculation algorithm. Similarly, the dose in OARs was in most cases consistently higher with TG43. Table 1 presents the results for each anatomical site, listing mean and maximum deviations in key DVH metrics for PTV and OARs between the two algorithms. An illustrative example is shown in Figure 1 where the absolute dose distribution differences between the two algorithms are shown for two anatomical sites.

Figure 1: Distribution of dose difference, between the dose calculated by the AAPM TG43 and AcurosTM BV algorithms (TG43 – AcurosBV), for a breast (top) and a head-and-neck (bottom) case.

Conclusion